Filter
Period
Filter by
recent search
Showing: 1 – 05 of 125 Regulated Information
–
11 April 2023
11 April 2023
LinkedIn
Facebook
Ipsen SA – Monthly information relative to the total number of voting rights and shares composing the share capital
Monthly information relative to the total number of voting rights and shares composing the share capital
–
06 April 2023
06 April 2023
LinkedIn
Ipsen S.A. publishes its 2022 Universal registration document
Regulated Information
–
10 March 2023
10 March 2023
LinkedIn
Ipsen SA – Monthly information relative to the total number of voting rights and shares composing the share capital
Monthly information relative to the total number of voting rights and shares composing the share capital
–
10 March 2023
10 March 2023
LinkedIn
Voting rights on 28 February 2023
This article or press release has no online content. Please download the associated documents for more information.
–
02 March 2023
02 March 2023
LinkedIn
Ipsen completes acquisition of Albireo, expanding the scope of its Rare Disease portfolio
PARIS, FRANCE, 3 March 2023 – Ipsen (Euronext: IPN: ADR: IPSEY) today announced it has completed the acquisition of Albireo Pharma, Inc., a leading innovator in bile-acid modulators to treat rare liver conditions. The acquisition enriches Ipsen’s Rare Disease portfolio, with…